These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32114374)

  • 41. Potential for Reducing Time to Referral for Colorectal Cancer Patients in Primary Care.
    van Erp NF; Helsper CW; Olyhoek SM; Janssen RRT; Winsveen A; Peeters PHM; de Wit NJ
    Ann Fam Med; 2019 Sep; 17(5):419-427. PubMed ID: 31501203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study.
    Donnelly C; Quaife S; Forbes L; Boylan J; Tishelman C; Gavin A
    Eur J Public Health; 2017 Oct; 27(5):808-813. PubMed ID: 28957476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary care characteristics and stage of cancer at diagnosis using data from the national cancer registration service, quality outcomes framework and general practice information.
    Maclean R; Jeffreys M; Ives A; Jones T; Verne J; Ben-Shlomo Y
    BMC Cancer; 2015 Jul; 15():500. PubMed ID: 26141458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends and inequities in colorectal cancer screening participation in Ontario, Canada, 2005-2011.
    Honein-AbouHaidar GN; Baxter NN; Moineddin R; Urbach DR; Rabeneck L; Bierman AS
    Cancer Epidemiol; 2013 Dec; 37(6):946-56. PubMed ID: 23702337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer staging at diagnosis data comparisons in South Australia.
    Meng R; Venugopal K; Thomas H; D'Onise K
    Sci Rep; 2020 Jan; 10(1):1008. PubMed ID: 31974401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study.
    Myklebust TÅ; Andersson T; Bardot A; Vernon S; Gavin A; Fitzpatrick D; Jerm MB; Rutherford M; Parkin DM; Sasieni P; Arnold M; Soerjomataram I; Bray F; Lambert PC; Møller B
    Cancer Epidemiol; 2020 Aug; 67():101759. PubMed ID: 32544801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
    Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
    Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care.
    Nilbert M; Thomsen LA; Winther Jensen J; Møller H; Borre M; Widenlou Nordmark A; Lambe M; Brändström H; Kørner H; Møller B; Ursin G
    Acta Oncol; 2020 Nov; 59(11):1343-1356. PubMed ID: 32981417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-standardized cancer-incidence trends in Canada, 1971-2015.
    Brenner DR; Ruan Y; Shaw E; O'Sullivan D; Poirier AE; Heer E; Villeneuve PJ; Walter SD; Friedenreich CM; Smith L; De P
    CMAJ; 2019 Nov; 191(46):E1262-E1273. PubMed ID: 31740536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study.
    Dregan A; Moller H; Murray-Thomas T; Gulliford MC
    Cancer Epidemiol; 2012 Oct; 36(5):425-9. PubMed ID: 22727737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data.
    Woods LM; Coleman MP; Lawrence G; Rashbass J; Berrino F; Rachet B
    BMJ; 2011 Jun; 342():d3399. PubMed ID: 21659366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ascertainment of cancer in longitudinal research: The concordance between the Rotterdam Study and the Netherlands Cancer Registry.
    van der Willik KD; Ruiter R; van Rooij FJA; Verkroost-van Heemst J; Hogewoning SJ; Timmermans KCAA; Visser O; Schagen SB; Ikram MA; Stricker BHC
    Int J Cancer; 2020 Aug; 147(3):633-640. PubMed ID: 31642518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Agreement between oral contraceptive users and prescribers: implications for case-control studies.
    van Leeuwen FE; van Duijn CM; Camps MH; Kempers BA; Mentjens MF; Mulder HB; Schouten EG; Zwijsen RM; Rookus MA
    Contraception; 1992 May; 45(5):399-408. PubMed ID: 1623713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening.
    Gentry-Maharaj A; Fourkala EO; Burnell M; Ryan A; Apostolidou S; Habib M; Sharma A; Parmar M; Jacobs I; Menon U
    Br J Cancer; 2013 Nov; 109(11):2875-9. PubMed ID: 24129231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stage at diagnosis and early mortality from cancer in England.
    McPhail S; Johnson S; Greenberg D; Peake M; Rous B
    Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nordic Cancer Registries - an overview of their procedures and data comparability.
    Pukkala E; Engholm G; Højsgaard Schmidt LK; Storm H; Khan S; Lambe M; Pettersson D; Ólafsdóttir E; Tryggvadóttir L; Hakanen T; Malila N; Virtanen A; Johannesen TB; Larønningen S; Ursin G
    Acta Oncol; 2018 Apr; 57(4):440-455. PubMed ID: 29226751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased consultation frequency in primary care, a risk marker for cancer: a case-control study.
    Ewing M; Naredi P; Nemes S; Zhang C; Månsson J
    Scand J Prim Health Care; 2016 Jun; 34(2):205-12. PubMed ID: 27189513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of bone metastases in breast cancer patients in the United Kingdom: results of a multi-database linkage study using the general practice research database.
    Hagberg KW; Taylor A; Hernandez RK; Jick S
    Cancer Epidemiol; 2013 Jun; 37(3):240-6. PubMed ID: 23416031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10.
    Elwood JM; Aye PS; Tin Tin S
    PLoS One; 2016; 11(3):e0150734. PubMed ID: 26938056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The validity of self-reported cancer in an Australian population study.
    Loh V; Harding J; Koshkina V; Barr E; Shaw J; Magliano D
    Aust N Z J Public Health; 2014 Feb; 38(1):35-8. PubMed ID: 24494943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.